Skip to main navigation
Skip to search
Skip to main content
Penn State Home
Help & FAQ
Home
Researchers
Research output
Research units
Equipment
Grants & Projects
Prizes
Activities
Search by expertise, name or affiliation
Use of Bisphosphonates in Patients with Metastatic Bone Disease
James R. Berenson, Allan Lipton
Department of Medicine
Penn State Cancer Institute
Division of Hematology and Oncology
Research output
:
Contribution to journal
›
Article
›
peer-review
13
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Use of Bisphosphonates in Patients with Metastatic Bone Disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Bisphosphonates
100%
Metastatic Bone Disease
100%
Bone Resorption
66%
Tumor
33%
Multiple Myeloma
33%
Bone Metastasis
33%
Skeletal Complications
33%
Breast Cancer
33%
Osteoclast
33%
Disease-associated
33%
Hypercalcemia
33%
Cancer-related
33%
Osteolytic Metastasis
33%
Osteoclast Activation
33%
Lytic Bone Disease
33%
Randomized Double-blind Study
33%
Paget's Disease of Bone
33%
Tumor-induced Osteolysis
33%
Osteoclastic Activity
33%
Pharmacology, Toxicology and Pharmaceutical Science
Bisphosphonic Acid Derivative
100%
Bone Disease
100%
Bone Metastasis
66%
Neoplasm
66%
Malignant Neoplasm
33%
Breast Cancer
33%
Multiple Myeloma
33%
Disease
33%
Hypercalcaemia
33%
Biochemistry, Genetics and Molecular Biology
Osteolysis
100%
Osteoclast Activity
33%
Hypercalcaemia
33%
Osteoclast
33%
Medicine and Dentistry
Paget Bone Disease
33%